Skip to content

Efficacy Study of a Cosmetic Lotion in the Treatment of Alopecia Areata in Males and Females

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02604888
Acronym
MEXISAREATA
Enrollment
20
Registered
2015-11-16
Start date
2015-10-31
Completion date
2017-10-31
Last updated
2017-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alopecia Areata

Keywords

Baldness, Alopecia Areata, Alopecia, Hair loss

Brief summary

The purpose of this study is to determine whether the Hair Loss Prevention Lotion named MEXIS, M.P.A.F., M6S PATENT is effective in the treatment of Alopecia Areata.

Detailed description

This study verifies whether the tested product has any efficacy in the treatment of Alopecia Areata. * The evaluated product (Hair Loss prevention Lotion) is called: MEXIS, MPAF, M6S PATENT. * 20 volunteers both men and women suffering from hair loss both in parties and over the entire scalp with age between 18 and 70 years will be selected for this test . * Samples of the product have been applied following their usual use: as they are. * On the selecting volunteers will be used: A polarized light video-camera to check the redness of the scalp and to have a picture of hair and scalp. * Volunteers will also be asked about: * Fluffiness * Sheen * Itching * Presence of scales on scalp * Oily hair * Product's acceptability * The readings will be taken at 0 time (basal value), after 15 days (t15), 30 days (t30), 45 days (t45), 45 days (t45), 60 days (t60) and 90 days (t90) by the experimenter in the medical studio. Then they analyzed and reported in a graph. * Summarizing tables and graphs of the data will be taken during experimentation.

Interventions

OTHERMEXIS/M6S Patent - lotion against alopecia

For greatest problems 20 drops on the scalp per day for 6 months. For minor problems 10 drops on the scalp three times per week for 6 months.

Sponsors

Mexis George
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Good state of general health * Suffering from Alopecia Areata * No pharmacological treatment in progress * Promise not to change the usual daily routine * No atopy in the anamnesis

Exclusion criteria

* Illness * Good state of hair * Pharmacological treatment in progress * Denial of the continuance of the usual daily routine * Atopy in the anamnesis

Design outcomes

Primary

MeasureTime frameDescription
Change of the Density of the Hair measured with a camerabaseline and 180 daysChange on the total amount of head's hair

Secondary

MeasureTime frameDescription
Change of the Amount of Hair Lossbaseline and 180 daysChange on the amount of hair fallen per day

Countries

Greece

Contacts

Primary ContactSandy Matzakoni, Controller
info@mexis.gr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026